
### [MONDO:0009043](http://purl.obolibrary.org/obo/MONDO_0009043)
**Label:** generalized resistance to thyroid hormone

**Subclasses:** [MONDO:0019854](http://purl.obolibrary.org/obo/MONDO_0019854) (thyroid ectopia), [MONDO:0019855](http://purl.obolibrary.org/obo/MONDO_0019855) (Athyreosis), [MONDO:0009154](http://purl.obolibrary.org/obo/MONDO_0009154) (hypothyroidism, congenital, Nongoitrous, 5), [MONDO:0019861](http://purl.obolibrary.org/obo/MONDO_0019861) (thyroid hypoplasia), [MONDO:0010131](http://purl.obolibrary.org/obo/MONDO_0010131) (thyroid hormone resistance, generalized, autosomal recessive), [MONDO:0019860](http://purl.obolibrary.org/obo/MONDO_0019860) (thyroid hemiagenesis), [MONDO:0008569](http://purl.obolibrary.org/obo/MONDO_0008569) (thyroid hormone resistance, generalized, autosomal dominant), 

**Mapped go classes:** [GO:0048839](http://purl.obolibrary.org/obo/GO_0048839) (inner ear development), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0003231](http://purl.obolibrary.org/obo/GO_0003231) (cardiac ventricle development), [GO:0060840](http://purl.obolibrary.org/obo/GO_0060840) (artery development), [GO:0043401](http://purl.obolibrary.org/obo/GO_0043401) (steroid hormone mediated signaling pathway), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0003007](http://purl.obolibrary.org/obo/GO_0003007) (heart morphogenesis), [GO:0003205](http://purl.obolibrary.org/obo/GO_0003205) (cardiac chamber development), [GO:0001076](http://purl.obolibrary.org/obo/GO_0001076) (transcription factor activity, RNA polymerase II transcription factor binding), [GO:0043010](http://purl.obolibrary.org/obo/GO_0043010) (camera-type eye development), [GO:0070324](http://purl.obolibrary.org/obo/GO_0070324) (thyroid hormone binding), [GO:0001947](http://purl.obolibrary.org/obo/GO_0001947) (heart looping), [GO:0003707](http://purl.obolibrary.org/obo/GO_0003707) (steroid hormone receptor activity), [GO:0055007](http://purl.obolibrary.org/obo/GO_0055007) (cardiac muscle cell differentiation), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:1901210](http://purl.obolibrary.org/obo/GO_1901210) (regulation of cardiac chamber formation), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0061626](http://purl.obolibrary.org/obo/GO_0061626) (pharyngeal arch artery morphogenesis), [GO:0035050](http://purl.obolibrary.org/obo/GO_0035050) (embryonic heart tube development), [GO:0002154](http://purl.obolibrary.org/obo/GO_0002154) (thyroid hormone mediated signaling pathway), [GO:0046549](http://purl.obolibrary.org/obo/GO_0046549) (retinal cone cell development), [GO:0060038](http://purl.obolibrary.org/obo/GO_0060038) (cardiac muscle cell proliferation), [GO:0048703](http://purl.obolibrary.org/obo/GO_0048703) (embryonic viscerocranium morphogenesis), [GO:0004887](http://purl.obolibrary.org/obo/GO_0004887) (thyroid hormone receptor activity), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0000790](http://purl.obolibrary.org/obo/GO_0000790) (nuclear chromatin), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), 

**Class expressions from DL-Learner:**

- [GO:0060038](http://purl.obolibrary.org/obo/GO_0060038) (cardiac muscle cell proliferation) 54.17%
- Thing 52.22%
- [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) 39.95%
- [GO:0033002](http://purl.obolibrary.org/obo/GO_0033002) (muscle cell proliferation) 39.52%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) 39.52%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) or [GO:2001221](http://purl.obolibrary.org/obo/GO_2001221) (obsolete positive regulation of G2 phase of mitotic cell cycle)) 39.52%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) or [GO:2001220](http://purl.obolibrary.org/obo/GO_2001220) (obsolete negative regulation of G2 phase of mitotic cell cycle)) 39.52%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) or [GO:2001219](http://purl.obolibrary.org/obo/GO_2001219) (obsolete positive regulation of S/G2 transition of mitotic cell cycle)) 39.52%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) or [GO:2001218](http://purl.obolibrary.org/obo/GO_2001218) (obsolete negative regulation of S/G2 transition of mitotic cell cycle)) 39.52%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) or [GO:2001217](http://purl.obolibrary.org/obo/GO_2001217) (obsolete regulation of S/G2 transition of mitotic cell cycle)) 39.52%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) or [GO:2001052](http://purl.obolibrary.org/obo/GO_2001052) (null)) 39.52%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) or [GO:2001048](http://purl.obolibrary.org/obo/GO_2001048) (null)) 39.52%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) or [GO:2001047](http://purl.obolibrary.org/obo/GO_2001047) (null)) 39.52%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) or [GO:2001041](http://purl.obolibrary.org/obo/GO_2001041) (null)) 39.52%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) or [GO:2000976](http://purl.obolibrary.org/obo/GO_2000976) (obsolete regulation of transcription from RNA polymerase II promoter involved in detection of glucose)) 39.52%


